Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

作者: Peter W Horby , Marion Mafham , Jennifer L Bell , Louise Linsell , Natalie Staplin

DOI: 10.1016/S0140-6736(20)32013-4

关键词:

摘要: … trial to assess whether lopinavir–ritonavir … lopinavir–ritonavir and usual care and hence are not included in this report. Patients allocated to lopinavir–ritonavir were to receive lopinavir …

参考文章(28)
Jasper Fuk-Woo Chan, Yanfeng Yao, Man-Lung Yeung, Wei Deng, Linlin Bao, Lilong Jia, Fengdi Li, Chong Xiao, Hong Gao, Pin Yu, Jian-Piao Cai, Hin Chu, Jie Zhou, Honglin Chen, Chuan Qin, Kwok-Yung Yuen, Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset The Journal of Infectious Diseases. ,vol. 212, pp. 1904- 1913 ,(2015) , 10.1093/INFDIS/JIV392
Brookie M. Best, Edmund V. Capparelli, Huy Diep, Steven S. Rossi, Michael J. Farrell, Elaine Williams, Grace Lee, John N. van den Anker, Natella Rakhmanina, Pharmacokinetics of lopinavir/ritonavir crushed versus whole tablets in children. Journal of Acquired Immune Deficiency Syndromes. ,vol. 58, pp. 385- 391 ,(2011) , 10.1097/QAI.0B013E318232B057
Veena Nukoolkarn, Vannajan Sanghiran Lee, Maturos Malaisree, Ornjira Aruksakulwong, Supot Hannongbua, Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors Journal of Theoretical Biology. ,vol. 254, pp. 861- 867 ,(2008) , 10.1016/J.JTBI.2008.07.030
Adriaan H. de Wilde, Dirk Jochmans, Clara C. Posthuma, Jessika C. Zevenhoven-Dobbe, Stefan van Nieuwkoop, Theo M. Bestebroer, Bernadette G. van den Hoogen, Johan Neyts, Eric J. Snijder, Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture Antimicrobial Agents and Chemotherapy. ,vol. 58, pp. 4875- 4884 ,(2014) , 10.1128/AAC.03011-14
CM Chu, VCC Cheng, IFN Hung, MML Wong, KH Chan, KS Chan, RYT Kao, LLM Poon, CLP Wong, Y Guan, JSM Peiris, KY Yuen, None, Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax. ,vol. 59, pp. 252- 256 ,(2004) , 10.1136/THORAX.2003.012658
F Chen, K.H Chan, Y Jiang, R.Y.T Kao, H.T Lu, K.W Fan, V.C.C Cheng, W.H.W Tsui, I.F.N Hung, T.S.W Lee, In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Journal of Clinical Virology. ,vol. 31, pp. 69- 75 ,(2004) , 10.1016/J.JCV.2004.03.003
Timothy P. Sheahan, Amy C. Sims, Sarah R. Leist, Alexandra Schäfer, John Won, Ariane J. Brown, Stephanie A. Montgomery, Alison Hogg, Darius Babusis, Michael O. Clarke, Jamie E. Spahn, Laura Bauer, Scott Sellers, Danielle Porter, Joy Y. Feng, Tomas Cihlar, Robert Jordan, Mark R. Denison, Ralph S. Baric, Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications. ,vol. 11, pp. 222- 222 ,(2020) , 10.1038/S41467-019-13940-6
Xin Liu, Xiu-Jie Wang, Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines. Journal of Genetics and Genomics. ,vol. 47, pp. 119- 121 ,(2020) , 10.1016/J.JGG.2020.02.001
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei, Xingwang Li, Jiaan Xia, Nanshan Chen, Jie Xiang, Ting Yu, Tao Bai, Xuelei Xie, Li Zhang, Caihong Li, Ye Yuan, Hua Chen, Huadong Li, Hanping Huang, Shengjing Tu, Fengyun Gong, Ying Liu, Yuan Wei, Chongya Dong, Fei Zhou, Xiaoying Gu, Jiuyang Xu, Zhibo Liu, Yi Zhang, Hui Li, Lianhan Shang, Ke Wang, Kunxia Li, Xia Zhou, Xuan Dong, Zhaohui Qu, Sixia Lu, Xujuan Hu, Shunan Ruan, Shanshan Luo, Jing Wu, Lu Peng, Fang Cheng, Lihong Pan, Jun Zou, Chunmin Jia, Juan Wang, Xia Liu, Shuzhen Wang, Xudong Wu, Qin Ge, Jing He, Haiyan Zhan, Fang Qiu, Li Guo, Chaolin Huang, Thomas Jaki, Frederick G. Hayden, Peter W. Horby, Dingyu Zhang, Chen Wang, A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19. The New England Journal of Medicine. ,vol. 382, pp. 1787- 1799 ,(2020) , 10.1056/NEJMOA2001282
Robert Verity, Lucy C Okell, Ilaria Dorigatti, Peter Winskill, Charles Whittaker, Natsuko Imai, Gina Cuomo-Dannenburg, Hayley Thompson, Patrick G T Walker, Han Fu, Amy Dighe, Jamie T Griffin, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Anne Cori, Zulma Cucunubá, Rich FitzJohn, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Daniel Laydon, Gemma Nedjati-Gilani, Steven Riley, Sabine van Elsland, Erik Volz, Haowei Wang, Yuanrong Wang, Xiaoyue Xi, Christl A Donnelly, Azra C Ghani, Neil M Ferguson, Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infectious Diseases. ,vol. 20, pp. 669- 677 ,(2020) , 10.1016/S1473-3099(20)30243-7